New Leaf Biopharma Opportunities II Overview
- Fund Type
-
Growth/Expansion
- Fund Status
-
Closed
- Fund Manager
- New Leaf Venture
- Size
-
- Vintage
-
2018
- Dry Powder
-
New Leaf Biopharma Opportunities II General Information
Description
New Leaf Biopharma Opportunities II is a 2018 vintage private equity growth-expansion fund managed by New Leaf Venture. The fund is based in New York, New York, and invests in the United States. The fund targets pharmaceuticals and biotechnology companies.
Contact Information
Fund Manager's Location
- 156 Fifth Avenue
- Suite 820
- New York, NY 10010
- United States
New Leaf Biopharma Opportunities II Investments (7)
New Leaf Biopharma Opportunities II has made a total of 7 investments. Its most recent deal was a with Edgewise Therapeutics for . The deal was made on 08-Dec-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Edgewise Therapeutics | 08-Dec-2020 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Saniona | 10-Aug-2020 | Drug Delivery | Generating Revenue | |||
| Harpoon Therapeutics | 11-Nov-2018 | Drug Discovery | Generating Revenue | |||
| Alector | 25-Jul-2018 | Drug Discovery | Startup | |||
| Arvinas | 04-Apr-2018 | Later Stage VC (Series C) | Drug Discovery | Generating Revenue |
New Leaf Biopharma Opportunities II Investment Strategy
Investments by Industry
Investments by Deal Type
New Leaf Biopharma Opportunities II Limited Partners (2)
Michigan Department of Treasury is one of New Leaf Biopharma Opportunities II’s 2 limited partners. Its latest Original was on 31-Dec-2018.
| Limited Partner Name | Type | Status | Commitment | Date | Commitment Type |
|---|---|---|---|---|---|
| Michigan Department of Treasury | Current | 31-Dec-2018 | Original | ||
| State of Michigan Retirement Systems | Public Pension Fund | Current | 31-Dec-2018 | Original |
New Leaf Biopharma Opportunities II Returns Data
The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.
IRR (%)
DPI (x)
RVPI (x)
TVPI (x)
New Leaf Biopharma Opportunities II Returns History
| Period | Contribution (by all LPs) | Dry Powder | Distribution (to all LPs) | NAV | Total Fund Distr+NAV | IRR | DPI | RVPI | TVPI | Dry Powder % |
|---|
New Leaf Biopharma Opportunities II Benchmark (326)
| Fund Name | Fund Type | Vintage | IRR | Quartile | As of Date |
|---|---|---|---|---|---|
| Elsewhere Partners I | |||||
| Savory Fund I | 30-Sep-2022 | ||||
| West Lane Capital Partners Private Equity Fund | |||||
| SLP Zephyr Investors | 31-Dec-2024 | ||||
| Monogram Capital Partners I | |||||
| Teng Yue Partners RDLT | |||||
| GP China Venture Capital II | |||||
| Sage Equity Partners WH | |||||
| HCR Molag Fund | |||||
| SP Aqua Investors |
New Leaf Biopharma Opportunities II FAQs
-
What is New Leaf Biopharma Opportunities II?
New Leaf Biopharma Opportunities II is a 2018 vintage private equity growth-expansion fund managed by New Leaf Venture.
-
Who manages New Leaf Biopharma Opportunities II?
New Leaf Biopharma Opportunities II is managed by New Leaf Venture.
-
Where is New Leaf Biopharma Opportunities II domiciled?
New Leaf Biopharma Opportunities II is domiciled in United States: Delaware.
-
What is New Leaf Biopharma Opportunities II's size?
New Leaf Biopharma Opportunities II has a size of .
-
What type of fund is New Leaf Biopharma Opportunities II?
The fund type of New Leaf Biopharma Opportunities II is Growth/Expansion.
-
What is the status of New Leaf Biopharma Opportunities II?
New Leaf Biopharma Opportunities II is closed.
-
What has New Leaf Biopharma Opportunities II invested in?
New Leaf Biopharma Opportunities II has made numerous investments in companies like Edgewise Therapeutics, Saniona, and Harpoon Therapeutics within the Drug Discovery and Drug Delivery industries.
-
What has New Leaf Biopharma Opportunities II invested in recently?
New Leaf Biopharma Opportunities II's latest investment was on 08-Dec-2020 in Edgewise Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
